You are here

CinCor Pharma

AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B

BioSpace

Mon, 01/9/23 - 10:41 am

CinCor shares dive after blood pressure drug fails key trial

BioPharma Dive

Mon, 11/28/22 - 07:36 pm

clinical trials

Biopharma flotations tank in the first quarter

EP Vantage

Thu, 04/7/22 - 10:11 am

Amylyx Pharmaceuticals

Vigil Neuroscience

AN2 Therapeutics

CinCor Raises $143 Million To Fund Innovation in Hypertension Research

BioSpace

Wed, 10/13/21 - 10:36 pm

chronic kidney disease

Quiet CinCor Pharma makes some noise with $143M, new trial plans for blood pressure drug

Endpoints

Tue, 10/12/21 - 11:10 am

clinical trials